Related Experiment Video
Updated: Dec 20, 2025
07:51
Video Movement Analysis Using Smartphones ViMAS: A Pilot Study
Published on: March 14, 2017
17.1K
[Mobile apps and their usage in rheumatology]
M Krusche1, N Ruffer2, M Grahammer3
1Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, Charité Universitätsmedizin, Charitéplatz 1, 10117, Berlin, Deutschland. martin.krusche@charite.de.
Zeitschrift Fur Rheumatologie
|May 31, 2020
Summary
Mobile applications offer significant benefits for chronically ill patients, particularly in rheumatology. Germany
Area of Science:
- Digital health
- Rheumatology
- Mobile applications
Background:
- Smartphone and mobile application usage is rapidly increasing.
- Chronically ill patients can significantly benefit from mobile health applications.
- The Digital Healthcare Act (DVG) in Germany enables legal claims for certain reimbursed digital health applications (DiGAs).
Purpose of the Study:
- To explore the potential benefits and risks of mobile applications in managing chronic rheumatic diseases.
- To provide an overview of the current digital health landscape for rheumatology apps in Germany.
Main Methods:
- Review of current literature and digital health trends in rheumatology.
- Analysis of the impact of the Digital Healthcare Act (DVG) on DiGA accessibility.
- Exploration of patient and rheumatologist interest in adopting mobile health solutions.
Main Results:
- Rheumatology presents numerous opportunities for app implementation in chronic disease management.
- Both patients with rheumatic conditions and rheumatologists show a growing interest in utilizing mobile applications.
- There is a developing digital landscape for rheumatology apps in Germany.
Conclusions:
- Mobile applications, especially DiGAs, hold considerable promise for improving chronic disease management in rheumatology.
- Understanding the opportunities and risks associated with these apps is crucial for successful integration into routine care.
- Further development and adoption of rheumatology-specific apps are anticipated in Germany.
More Related Videos
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
209
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
209
01:11Genome-wide Association Studies-GWAS
15.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.1K
01:23Rheumatic Heart Disease I: Introduction
326
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
326
01:20Rheumatic Heart Disease IV: Nursing Management
197
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
197
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
334
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
334
01:22Connective Tissue Cell Types
3.9K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.9K